» Articles » PMID: 36835266

The Journey of Cancer Cells to the Brain: Challenges and Opportunities

Abstract

Cancer metastases into the brain constitute one of the most severe, but not uncommon, manifestations of cancer progression. Several factors control how cancer cells interact with the brain to establish metastasis. These factors include mediators of signaling pathways participating in migration, infiltration of the blood-brain barrier, interaction with host cells (e.g., neurons, astrocytes), and the immune system. Development of novel therapies offers a glimpse of hope for increasing the diminutive life expectancy currently forecasted for patients suffering from brain metastasis. However, applying these treatment strategies has not been sufficiently effective. Therefore, there is a need for a better understanding of the metastasis process to uncover novel therapeutic targets. In this review, we follow the journey of various cancer cells from their primary location through the diverse processes that they undergo to colonize the brain. These processes include EMT, intravasation, extravasation, and infiltration of the blood-brain barrier, ending up with colonization and angiogenesis. In each phase, we focus on the pathways engaging molecules that potentially could be drug target candidates.

Citing Articles

Single-cell and spatial transcriptomics reveal a potential role of ATF3 in brain metastasis of lung adenocarcinoma.

Xu C, Bao J, Pan D, Wei K, Gao Q, Lin W Transl Lung Cancer Res. 2025; 14(1):209-223.

PMID: 39958219 PMC: 11826269. DOI: 10.21037/tlcr-24-784.


Opioid System and Epithelial-Mesenchymal Transition.

Lazarczyk M, Skiba D, Mickael M, Jaskula K, Nawrocka A, Religa P Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861181 PMC: 11768736. DOI: 10.3390/ph18010120.


Breaking boundaries: role of the brain barriers in metastatic process.

Izadi N, Solar P, Hasanova K, Zamani A, Akbar M, Mrazova K Fluids Barriers CNS. 2025; 22(1):3.

PMID: 39780275 PMC: 11708195. DOI: 10.1186/s12987-025-00618-z.


Current Evidence in the Systemic Treatment of Brain Metastases from Breast Cancer and Future Perspectives on New Drugs, Combinations and Administration Routes: A Narrative Review.

Garrone O, Ruatta F, Rea C, Denaro N, Ghidini M, Cauchi C Cancers (Basel). 2025; 16(24.

PMID: 39766062 PMC: 11675070. DOI: 10.3390/cancers16244164.


Using Copy Number Variation Data and Neural Networks to Predict Cancer Metastasis Origin Achieves High Area under the Curve Value with a Trade-Off in Precision.

Mickael M, Kubick N, Atanasov A, Martinek P, Horbanczuk J, Floretes N Curr Issues Mol Biol. 2024; 46(8):8301-8319.

PMID: 39194707 PMC: 11352492. DOI: 10.3390/cimb46080490.


References
1.
Deshmukh A, Vasaikar S, Tomczak K, Tripathi S, den Hollander P, Arslan E . Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing. Proc Natl Acad Sci U S A. 2021; 118(19). PMC: 8126782. DOI: 10.1073/pnas.2102050118. View

2.
Bambang I, Xu S, Zhou J, Salto-Tellez M, Sethi S, Zhang D . Overexpression of endoplasmic reticulum protein 29 regulates mesenchymal-epithelial transition and suppresses xenograft tumor growth of invasive breast cancer cells. Lab Invest. 2009; 89(11):1229-42. DOI: 10.1038/labinvest.2009.87. View

3.
Menter D, Herrmann J, Nicolson G . The role of trophic factors and autocrine/paracrine growth factors in brain metastasis. Clin Exp Metastasis. 1995; 13(2):67-88. DOI: 10.1007/BF00133612. View

4.
Reijneveld J, Voest E, Taphoorn M . Angiogenesis in malignant primary and metastatic brain tumors. J Neurol. 2000; 247(8):597-608. DOI: 10.1007/s004150070128. View

5.
Saykali B, El-Sibai M . Invadopodia, regulation, and assembly in cancer cell invasion. Cell Commun Adhes. 2014; 21(4):207-12. DOI: 10.3109/15419061.2014.923845. View